The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival
Kaitlyn Melnick(University of Florida), Maryam Rahman(University of Florida), Ethan Carmichael(University of Florida), David D. Tran(University of Florida), Patricia Miller(University of Florida), Ashley Ghiaseddin(University of Florida), Kyle McGrath(University of Florida)
Cited by 8
Related Papers
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
|JAMA Oncology|2022|411
An NAD <sup>+</sup> -dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma
|Proceedings of the National Academy of Sciences|2016|134
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
|Current Treatment Options in Oncology|2020|101